Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06100029Recruiting
Randomised, double-blind trial of Silexan in delirium (2 arms), sponsored by Chongqing Traditional Chinese Medicine Hospital. Primary endpoint: Prevalence of delirium. Started Nov 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06100029.